Institutional investors hold a majority ownership of NBIX through the 92.94% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2014, these large investors purchased a net $10.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMERALD ADVISERS, INC. Bought 22.4 Thousand shares of Neurocrine Biosciences In...